Patient Experiences with Compounded Topical Pain Creams.

Topical pain therapy offers several potential advantages as an alternative or adjunct to oral analgesic therapy, including decrease in concurrent oral drug use, lower abuse potential, lower side effects and toxicity, and localized effects. A variety of drugs and cream bases designed to promote transdermal delivery allow for unlimited customization of compounded topical pain creams (CTPC) for specific patients. The purpose of this study was to understand why patients begin CTPC therapy, their perceptions of CTPC therapy, and their level of satisfaction with CTPC therapy.

Patient experiences with compounded medications.

Objectives: There are few data directly from patients regarding their experiences with compounded prescriptions (CRx). The purpose of this study was to determine how patients initiated CRx use and how they perceived their CRx therapy.

Methods: A cross-sectional mailed national survey design was used.

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013.

Background: Although compounding has a long-standing tradition in clinical practice, insurers and pharmacy benefit managers have instituted policies to decrease claims for compounded medications, citing questions about their safety, efficacy, high costs, and lack of FDA approval. There are no reliable published data on the extent of compounding by community pharmacists nor on the fraction of patients who use compounded medications. Prior research suggests that compounded medications represent a relatively small proportion of prescription medications, but those surveys were limited by small sample sizes, subjective data collection methods, and low response rates.

Patient-centered care as value-added service by compounding pharmacists.

The term "value-added" is widely used to describe business and professional services that complement a product or service or that differentiate it from competing products and services. The objective of this study was to determine compounding pharmacists' self-perceptions of the value-added services they provide. A web-based survey method was used.

Patient-centered care in the community-based compounding practice setting.

Objective: To identify patient-centered care (PCC) functions delivered with compounded medications in the community pharmacy setting.

Design: Cross-sectional study.

Setting: United States during August to November 2007.

Independent community pharmacists' perspectives on compounding in contemporary pharmacy education.

Objectives: To identify compounding practices of independent community pharmacy practitioners in order to make recommendations for the development of curricular objectives for doctor of pharmacy (PharmD) programs.

Methods: Independent community practitioners were asked about compounding regarding their motivations, common activities, educational exposures, and recommendations for PharmD education.

Results: Most respondents (69%) accepted compounding as a component of pharmaceutical care and compounded dermatological preparations for local effects, oral solutions, and suspensions at least once a week.

Prevalence of compounding in independent community pharmacy practice.

Objectives: To determine the extent of prescription compounding in independent community pharmacies and identify factors that influence the decision of independent pharmacists whether to provide compounding services.

Design: Cross-sectional survey.

Setting: Illinois, Missouri, Kansas, and Iowa.